Deutsche Bank
CRBP icon

Deutsche Bank’s Corbus Pharmaceuticals CRBP Stock Holding History

Deutsche Bank’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$151K Buy
+16,071
New +$152K ﹤0.01% 3372
2025
Q2 		– Sell
-7,045
Closed -$37.4K – 3628
2025
Q1 		$37.4K Sell
7,045
-1,161
-14% -$10.2K ﹤0.01% 3419
2024
Q4 		$96.8K Buy
8,206
+2,616
+47% +$43.9K ﹤0.01% 3291
2024
Q3 		$115K Buy
5,590
+1,416
+34% +$72.5K ﹤0.01% 3169
2024
Q2 		$189K Buy
+4,174
New +$176K ﹤0.01% 2834
2021
Q3 		– Sell
-1,800
Closed -$98K – 4434
2021
Q2 		$98K Sell
1,800
-457
-20% -$25.4K ﹤0.01% 4153
2021
Q1 		$134K Buy
2,257
+412
+22% +$27.1K ﹤0.01% 3826
2020
Q4 		$70K Buy
1,845
+501
+37% +$18.7K ﹤0.01% 4014
2020
Q3 		$72K Buy
1,344
+232
+21% +$42K ﹤0.01% 3696
2020
Q2 		$280K Buy
1,112
+335
+43% +$67.7K ﹤0.01% 2949
2020
Q1 		$122K Buy
777
+62
+9% +$10.5K ﹤0.01% 3169
2019
Q4 		$117K Buy
715
+159
+29% +$23.5K ﹤0.01% 3511
2019
Q3 		$81K Sell
556
-89
-14% -$15.5K ﹤0.01% 3669
2019
Q2 		$132K Sell
645
-1,526
-70% -$327K ﹤0.01% 4060
2019
Q1 		$451K Buy
2,171
+181
+9% +$39.9K ﹤0.01% 3517
2018
Q4 		$348K Sell
1,990
-2,995
-60% -$598K ﹤0.01% 3556
2018
Q3 		$1.13M Sell
4,985
-3,390
-40% -$548K ﹤0.01% 3238
2018
Q2 		$1.27M Buy
8,375
+5,994
+252% +$1.09M ﹤0.01% 3265
2018
Q1 		$434K Sell
2,381
-1,447
-38% -$325K ﹤0.01% 3789
2017
Q4 		$814K Buy
3,828
+1,326
+53% +$284K ﹤0.01% 3338
2017
Q3 		$535K Sell
2,502
-2,543
-50% -$498K ﹤0.01% 3390
2017
Q2 		$952K Buy
5,045
+1,708
+51% +$335K ﹤0.01% 3063
2017
Q1 		$825K Buy
3,337
+4
+0.1% +$982 ﹤0.01% 2781
2016
Q4 		$845K Buy
3,333
+2,333
+233% +$535K ﹤0.01% 2823
2016
Q3 		$203K Buy
+1,000
New +$124K ﹤0.01% 3643

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Deutsche Bank's CRBP Position: Q2 2026 in Review

Deutsche Bank opened a new position in Corbus Pharmaceuticals (CRBP) in Q2 2026: 16,071 shares worth $151K. The stake represents ﹤0.01% of the portfolio and ranks #3372 among its holdings. This is a return to the name: Deutsche Bank previously reported a position in CRBP as recently as Q1 2025.

Deutsche Bank first reported a position in CRBP in Q3 2016 and has held it in 25 quarters since. The position peaked at $1.27M in Q2 2018. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • Deutsche Bank held 16,071 shares of Corbus Pharmaceuticals worth $151K as of Q2 2026.
  • Corbus Pharmaceuticals was a new Deutsche Bank position in Q2 2026.
  • Corbus Pharmaceuticals made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3372 holding.
  • Deutsche Bank first reported a position in Corbus Pharmaceuticals in Q3 2016 and has held it in 25 quarters since.
  • Deutsche Bank's Corbus Pharmaceuticals position peaked at $1.27M in Q2 2018.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.